India’s New Patent Regime: Impact On Global Pharmas
March 6, 2008, 12:00 AM EST
Law360, New York (March 6, 2008, 12:00 AM EST) -- It has been more than three years since the Indian Parliament passed the latest amendments to the India Patents Act of 1970 aimed at conforming India’s patent laws to the requirements set forth by the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
TRIPS sets down minimum standards for many forms of intellectual property protection that its member countries must provide. Notably, the new amendments allow for product patent protection for pharmaceuticals.
Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.